IL-27 receptor signaling regulates CD4+ T cell chemotactic responses during infection

Journal of Immunology

Volumn 190, Issue 9, 2013, Pages 4553-4561

  Findlay, Emily Gwyer ^a,f   Villegas Mendez, Ana ^a,c   De Souza, Brian J ^a,b   Inkson, Colette A ^c   Shaw, Tovah N ^a,c   Saris, Christiaan J ^d   Hunter, Christopher A ^e   Riley, Eleanor M ^a   Couper, Kevin N ^a,c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d AMGEN INC   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CXCL16 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 27 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; WILD TYPE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL4; CHEMOKINE CCL5; INFLAMMATION; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-2; INTERLEUKINS; MALARIA; MICE; MICE, INBRED C57BL; PLASMODIUM BERGHEI; RECEPTORS, CCR5; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-10; SIGNAL TRANSDUCTION; TH1 CELLS;

EID: 84876811708     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202916     Document Type: Article

References (41)

1. Yoshida, H., M. Nakaya, and Y. Miyazaki. 2009. Interleukin 27: a double-edged sword for offense and defense. J. Leukoc. Biol. 86: 1295-1303.
2. Hall, A. O., J. S. Silver, and C. A. Hunter. 2012. The immunobiology of IL-27. Adv. Immunol. 115: 1-44.
3. Findlay, E. G., R. Greig, J. S. Stumhofer, J. C. Hafalla, J. B. de Souza, C. J. Saris, C. A. Hunter, E. M. Riley, and K. N. Couper. 2010. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection. J. Immunol. 185: 2482-2492.
4. Villarino, A., L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, R. A. Kastelein, C. Saris, and C. A. Hunter. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19: 645-655. (Pubitemid 37490790)
5. Hamano, S., K. Himeno, Y. Miyazaki, K. Ishii, A. Yamanaka, A. Takeda, M. Zhang, H. Hisaeda, T. W. Mak, A. Yoshimura, and H. Yoshida. 2003. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19: 657-667. (Pubitemid 37490791)
6. Hölscher, C., A. Hölscher, D. Rückerl, T. Yoshimoto, H. Yoshida, T. Mak, C. Saris, and S. Ehlers. 2005. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol. 174: 3534-3544. (Pubitemid 40354062)
7. Artis, D., A. Villarino, M. Silverman, W. He, E. M. Thornton, S. Mu, S. Summer, T. M. Covey, E. Huang, H. Yoshida, et al. 2004. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173: 5626-5634. (Pubitemid 39392150)
8. Diveu, C., M. J. McGeachy, K. Boniface, J. S. Stumhofer, M. Sathe, B. Joyce-Shaikh, Y. Chen, C. M. Tato, T. K. McClanahan, R. de Waal Malefyt, et al. 2009. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol. 182: 5748-5756.
9. Lucas, S., N. Ghilardi, J. Li, and F. J. de Sauvage. 2003. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and-independent mechanisms. Proc. Natl. Acad. Sci. USA 100: 15047-15052. (Pubitemid 37518014)
10. Villarino, A. V., J. S. Stumhofer, C. J. Saris, R. A. Kastelein, F. J. de Sauvage, and C. A. Hunter. 2006. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 176: 237-247. (Pubitemid 43023268)
11. Awasthi, A., Y. Carrier, J. P. Peron, E. Bettelli, M. Kamanaka, R. A. Flavell, V. K. Kuchroo, M. Oukka, and H. L. Weiner. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8: 1380-1389. (Pubitemid 350131175)
12. Stumhofer, J. S., J. S. Silver, A. Laurence, P. M. Porrett, T. H. Harris, L. A. Turka, M. Ernst, C. J. Saris, J. J. O'Shea, and C. A. Hunter. 2007. Inter-leukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8: 1363-1371. (Pubitemid 350131173)
13. Pot, C., H. Jin, A. Awasthi, S. M. Liu, C. Y. Lai, R. Madan, A. H. Sharpe, C. L. Karp, S. C. Miaw, I. C. Ho, and V. K. Kuchroo. 2009. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183: 797-801.
14. Freitas do Rosário, A. P., T. Lamb, P. Spence, R. Stephens, A. Lang, A. Roers, W. Muller, A. O'Garra, and J. Langhorne. 2012. IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J. Immunol. 188: 1178-1190.
15. Rosas, L. E., A. A. Satoskar, K. M. Roth, T. L. Keiser, J. Barbi, C. Hunter, F. J. de Sauvage, and A. R. Satoskar. 2006. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to Leish-mania donovani infection but develop severe liver immunopathology. Am. J. Pathol. 168: 158-169. (Pubitemid 43062569)
16. Stumhofer, J. S., A. Laurence, E. H. Wilson, E. Huang, C. M. Tato, L. M. Johnson, A. V. Villarino, Q. Huang, A. Yoshimura, D. Sehy, et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7: 937-945. (Pubitemid 44263907)
17. Sallusto, F., and M. Baggiolini. 2008. Chemokines and leukocyte traffic. Nat. Immunol. 9: 949-952.
18. Sallusto, F., A. Lanzavecchia, and C. R. Mackay. 1998. Chemokines and che-mokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today 19: 568-574. (Pubitemid 28557120)
19. Sallusto, F., D. Lenig, C. R. Mackay, and A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187: 875-883. (Pubitemid 28141661)
20. Román, E., E. Miller, A. Harmsen, J. Wiley, U. H. Von Andrian, G. Huston, and S. L. Swain. 2002. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196: 957-968.
21. Sallusto, F., E. Kremmer, B. Palermo, A. Hoy, P. Ponath, S. Qin, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29: 2037-2045. (Pubitemid 29265560)
22. Bromley, S. K., T. R. Mempel, and A. D. Luster. 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9: 970-980.
23. Loetscher, P., M. Uguccioni, L. Bordoli, M. Baggiolini, B. Moser, C. Chizzolini, and J. M. Dayer. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature 391: 344-345.
24. Fujimoto, A., S. Takatsuka, I. Ishida, and J. Chiba. 2009. Production of human antibodies to native cytokine receptors using the genetic immunization of KM mice. Hum. Antibodies 18: 75-80.
25. Patterson, B. K., M. Czerniewski, J. Andersson, Y. Sullivan, F. Su, D. Jiyamapa, Z. Burki, and A. Landay. 1999. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes. Clin. Immunol. 91: 254-262. (Pubitemid 29250211)
26. Nakajima, C., T. Mukai, N. Yamaguchi, Y. Morimoto, W. R. Park, M. Iwasaki, P. Gao, S. Ono, H. Fujiwara, and T. Hamaoka. 2002. Induction of the chemokine receptor CXCR3 on TCR-stimulated T cells: dependence on the release from persistent TCR-triggering and requirement for IFN-gamma stimulation. Eur. J. Immunol. 32: 1792-1801.
27. Losana, G., C. Bovolenta, L. Rigamonti, I. Borghi, F. Altare, E. Jouanguy, G. Forni, J. L. Casanova, B. Sherry, M. Mengozzi, et al. 2002. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes. J. Leukoc. Biol. 72: 735-742. (Pubitemid 36277845)
28. Zhang, X., A. Niessner, T. Nakajima, W. Ma-Krupa, S. L. Kopecky, R. L. Frye, J. J. Goronzy, and C. M. Weyand. 2006. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ. Res. 98: 524-531.
29. Iwasaki, M., T. Mukai, C. Nakajima, Y. F. Yang, P. Gao, N. Yamaguchi, M. Tomura, H. Fujiwara, and T. Hamaoka. 2001. A mandatory role for STAT4 in IL-12 induction of mouse T cell CCR5. J. Immunol. 167: 6877-6883. (Pubitemid 33144180)
30. Yoshida, H., S. Hamano, G. Senaldi, T. Covey, R. Faggioni, S. Mu, M. Xia, A. C. Wakeham, H. Nishina, J. Potter, et al. 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15: 569-578. (Pubitemid 33016442)
31. Villegas-Mendez, A., J. B. de Souza, L. Murungi, J. C. Hafalla, T. N. Shaw, R. Greig, E. M. Riley, and K. N. Couper. 2011. Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection. J. Immunol. 187: 2885-2897.
32. Del Portillo, H. A., M. Ferrer, T. Brugat, L. Martin-Jaular, J. Langhorne, and M. V. Lacerda. 2012. The role of the spleen in malaria. Cell. Microbiol. 14: 343-355.
33. Villegas-Mendez, A., J. B. de Souza, S.-W. Lavelle, E. G. Findlay, T. N. Shaw, N. van Rooijen, C. J. Saris, C. A. Hunter, E. M. Riley, and K. N. Couper. 2013. IL-27 receptor signalling restricts the formation of pathogenic, terminally differentiated Th1 cells during malaria infection by repressing IL-12 dependent signals. PLoS Path. In press.
34. O'Garra, A. 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8: 275-283. (Pubitemid 28188888)
35. reg required to limit infection-induced pathology. Immunity 37: 511-523.
36. Wong, M. M., and E. N. Fish. 2003. Chemokines: attractive mediators of the immune response. Semin. Immunol. 15: 5-14. (Pubitemid 36092174)
37. Yoo, J. K., J. H. Cho, S. W. Lee, and Y. C. Sung. 2002. IL-12 provides proliferation and survival signals to murine CD4+ T cells through phosphatidylinositol 3-kinase/Akt signaling pathway. J. Immunol. 169: 3637-3643.
38. Ehsani, A., P. Saetrom, J. Zhang, J. Alluin, H. Li, O. Snøve, Jr., L. Aagaard, and J. J. Rossi. 2010. Rational design of micro-RNA-like bifunctional siRNAs targeting HIV and the HIV coreceptor CCR5. Mol. Ther. 18: 796-802.
39. Kim, S. H., K. V. Gunst, and N. Sarvetnick. 2006. STAT4/6-dependent differential regulation of chemokine receptors. Clin. Immunol. 118: 250-257. (Pubitemid 43199664)
40. Saccani, A., S. Saccani, S. Orlando, M. Sironi, S. Bernasconi, P. Ghezzi, A. Mantovani, and A. Sica. 2000. Redox regulation of chemokine receptor expression. Proc. Natl. Acad. Sci. USA 97: 2761-2766. (Pubitemid 30159245)
41. Li, J. P., H. Wu, W. Xing, S. G. Yang, S. H. Lu, W. T. Du, J. X. Yu, F. Chen, L. Zhang, and Z. C. Han. 2010. Interleukin-27 as a negative regulator of human neutrophil function. Scand. J. Immunol. 72: 284-292.